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Background:  The  reporting  of observational  studies  in  veterinary  research  presents  many  challenges  that
often  are  not adequately  addressed  in  published  reporting  guidelines.
Objective:  To  develop  an  extension  of  the  STROBE  (Strengthening  the  Reporting  of  Observational  Studies
in  Epidemiology)  statement  that  addresses  unique  reporting  requirements  for  observational  studies  in
veterinary  medicine  related  to health,  production,  welfare,  and  food  safety.
Design: A  consensus  meeting  of  experts  was  organized  to  develop  an  extension  of the  STROBE  statement
to  address  observational  studies  in  veterinary  medicine  with  respect  to  animal  health,  animal  production,
animal  welfare,  and  food  safety  outcomes.
Setting:  Consensus  meeting  May 11–13,  2014  in Mississauga,  Ontario,  Canada.
Participants:  Seventeen  experts  from  North  America,  Europe,  and  Australia  attended  the  meeting.  The
experts were  epidemiologists  and  biostatisticians,  many  of  whom  hold  or have  held  editorial  positions
with  relevant  journals.
Methods: Prior  to the  meeting,  19  experts  completed  a  survey  about  whether  they felt any  of the 22  items
of  the STROBE  statement  should  be modiﬁed  and  if items  should  be added  to  address  unique  issues  related
to  observational  studies  in  animal  species  with  health,  production,  welfare,  or food  safety  outcomes.  At
the  meeting,  the participants  were  provided  with  the  survey  responses  and  relevant  literature  concerning
the  reporting  of  veterinary  observational  studies.  During  the  meeting,  each  STROBE  item  was  discussed
to  determine  whether  or not  re-wording  was recommended,  and  whether  additions  were  warranted.
Anonymous  voting  was  used  to  determine  whether  there  was  consensus  for each  item  change  or  addition.
 Note: In order to encourage dissemination of the STROBE-Vet Statement, this article is published in the following journals: Journal of Food Protection, Journal of Swine
ealth and Production, Journal of Veterinary Internal Medicine, Preventive Veterinary Medicine, Zoonoses and Public Health. The Explanation and Elaboration STROBE-Vet
ocument for each checklist item is available in companion publications in Journal of Veterinary Internal Medicine and Zoonoses and Public Health. The original STROBE
tatement is published in the Journal of Clinical Epidemiology Web  site (http://www.jclinepi.com), Annals of Internal Medicine, BMJ, Bulletin of the World Health Organization,
pidemiology, The Lancet, PLoS Medicine, and Preventive Medicine. The authors jointly own  the copyright of this article.
∗ Corresponding author at: Centre for Public Health and Zoonoses, University of Guelph, Guelph, ON, Canada.
E-mail address: sargeanj@uoguelph.ca (J.M. Sargeant).
ttp://dx.doi.org/10.1016/j.prevetmed.2016.09.005
167-5877/© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
/).
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Results:  The  consensus  was  that six  items  needed  no  modiﬁcations  or additions.  Modiﬁcations  or  additions
were made  to the  STROBE  items  numbered:  1 (title  and  abstract),  3 (objectives),  5 (setting),  6 (partici-
pants),  7 (variables),  8 (data  sources/measurement),  9 (bias),  10  (study  size),  12  (statistical  methods),
13  (participants),  14  (descriptive  data),  15  (outcome  data),  16  (main  results),  17  (other  analyses),  19
(limitations),  and  22  (funding).
Limitation:  Published  literature  was  not  always  available  to support  modiﬁcation  to,  or  inclusion  of,  an
item.
Conclusion:  The  methods  and  processes  used  in the development  of this  statement  were  similar  to  those
used  for  other  extensions  of  the STROBE  statement.  The  use  of  this  extension  to  the  STROBE  statement
should  improve  the  reporting  of  observational  studies  in  veterinary  research  related  to  animal  health,
production,  welfare,  or food  safety  outcomes  by  recognizing  the unique  features  of observational  studies
involving  food-producing  and  companion  animals,  products  of  animal  origin,  aquaculture,  and  wildlife.
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. Introduction
Observational studies are a common methodological approach
n veterinary research and have been used to estimate the fre-
uency of a disease or condition, test hypotheses, generate new
ypotheses, or generate data suitable as input for systematic
eviews and meta-analyses, risk assessments, and other data-
ependent models, such as mathematical and simulated disease
odels. Thus, observational studies may  be used to estimate the
revalence or incidence of a condition, to investigate the distribu-
ion of conditions in time and space, to explore risk factors and
ompare management options, to create explanatory models, or to
valuate diagnostic test accuracy. Comprehensive and transparent
eporting of an observational study’s design, execution, and results
s essential for the interpretation of the research in terms of evalu-
ting its applicability for the reader and its potential for bias and for
he data to be used as input for other studies, such as meta-analyses
nd risk assessments. The peer-review process also beneﬁts from
uidelines describing appropriate reporting. In human healthcare,
nadequacies in reporting of key information in observational stud-
es have been documented (Tooth et al., 2005; Groenwold et al.,
008; Papathanasiou and Zintzaras, 2010). Although there is less
ocumented empirical evidence of deﬁciencies in reporting obser-
ational studies in veterinary medicine, absence of evidence is not
vidence of absence. Indeed, some evidence of inadequate report-
ng exists in the literature on pre-harvest food safety (Sargeant et al.,
011).
The STROBE statement (www.strobe-statement.org) was  devel-
ped to provide guidance for the reporting of observational studies
elated to human health. It consists of a 22-item checklist that is
ccompanied by a document describing the development of the
TROBE statement (von Elm et al., 2007) and an elaboration docu-
ent that provides explanations of each item, as well as examples
f complete reporting of each item (Vandenbroucke et al., 2007).
he STROBE guidelines focus on cohort, case-control, and cross-
ectional studies of aspects of human medicine and public health,
lthough many of the principles also apply to other observational
tudy designs, such as hybrid designs or ecological studies. The
TROBE statement has been modiﬁed for use in speciﬁc content
reas within epidemiology, including genetic-association studies
STREGA) (Little et al., 2009), molecular epidemiology (STROBE-
E)  (Gallo et al., 2012), and molecular epidemiology for infectious
iseases (STROME-ID) (Field et al., 2014).
There are some nuances of conducting and reporting studies
n animal populations that are unique from other areas of epi-
emiology (Sargeant and O’Connor, 2014). Thus, the CONsolidated
tandards Of Reporting Trials (CONSORT) statement for report-
ng randomized controlled trials in human medicine (Moher et al.,
001) was previously modiﬁed for use in veterinary medicine. Thehed  by  Elsevier  B.V. This is  an  open  access  article  under the  CC  BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
result was  the creation and publication of the reporting guide-
lines for randomized controlled trials for livestock and food safety
(REFLECT) statement (O’Connor et al., 2010; Sargeant et al., 2010).
Similarly, while the STROBE statement and the accompanying
elaboration document provide an excellent resource for conduct-
ing, reporting, and reading observational studies, modiﬁcations
to address speciﬁc issues in veterinary medicine will increase its
applicability in this ﬁeld (Sargeant and O’Connor, 2014).
Here, we describe the methods and processes used to develop
an extension of the STROBE statement that forms the basis for the
standardized reporting guidelines for observational studies in vet-
erinary medicine (STROBE-Vet). As a separate companion paper,
the STROBE-Vet explanation and elaboration document (O’Connor
et al., 2016a, 2016b) provides the methodological background for
the items contained in the STROBE-Vet statement, as well as illus-
trative examples of appropriate reporting. We strongly recommend
that the STROBE-Vet checklist be used in conjunction with the
explanation and elaboration document for all observational stud-
ies related to animal health, production, welfare, or food safety
outcomes.
2. Methods
The process for extending reporting-guideline statements (e.g.,
STROBE and CONSORT) to meet the speciﬁc needs of individual dis-
ciplines has been documented (Boutron et al., 2008; Moher et al.,
2010). We  used these reports to design the approach used for devel-
oping the statement reported herein.
2.1. Steering committee
A steering committee was responsible for the development of
the revised veterinary extension of the STROBE statement. This
group, comprised of four members (co-authors JMS, AMOC, HNE,
and IRD), ﬁrst met  to discuss the idea in December 2012. The
committee agreed to explore the need for modifying the original
STROBE statement and to use the approach reported previously as a
guideline for the modiﬁcation (Moher et al., 2010). The committee
secured funding for the project, identiﬁed potential participants,
invited the potential participants to attend a consensus meeting,
organized the meeting, and was responsible for subsequent steps
involved in preparation and publication of the papers as detailed
below.
2.2. FundingFunding was required to cover the costs of the consensus
meeting (e.g., travel, accommodations, and meeting rooms). The
decision was made by the steering committee not to seek funding
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rom pharmaceutical or biological companies commonly associated
ith veterinary research. Efforts to obtain funding were limited
o not-for-proﬁt non-government organizations, academic insti-
utions, and a publishing company. Funding was received from
he Canadian Association for Veterinary Epidemiology and Preven-
ive Medicine (CAVEPM), the Centre for Veterinary Epidemiology
CVER) at the University of Prince Edward Island, the Centre for
ublic Health and Zoonoses (CPHAZ) at the University of Guelph,
owa State University, Cornell University, and the publishing com-
any VER Inc, Prince Edward Island, Canada. Sufﬁcient funds were
btained to pay for all local expenses for the participants at the con-
ensus meeting. Funds to cover travel costs for participants were
ot obtained; therefore, in general, participants fully funded their
wn travel and the sources of these funds were not identiﬁed.
.3. Identiﬁcation of participants
The committee’s aim was to bring together a group of experts
amiliar with the design, conduct, and statistical analysis of obser-
ational studies concerning animal health, production, welfare, and
ood safety. Another aim was to include researchers with experi-
nce in a wide variety of areas, including food-animal production,
ompanion-animal medicine, veterinary public health, and food
afety. Representation from multiple countries was sought, with an
ffort to include several participants with relevant editorial expe-
ience.
The steering committee decided to limit the size of the meet-
ng to approximately 20 participants, including the four committee
embers. The size limitation was based on funding and the need for
 group size that facilitated interaction and active discussion. The
teering committee identiﬁed experts for invitation based on areas
f expertise (many with multiple areas) and geographic locations.
nvitations to attend the meeting were sent via email by JMS  to
he ﬁrst 20 individuals on the list. The email invitation requested
hat individuals wishing to participate commit to: a) completing
 pre-meeting survey to determine whether modiﬁcations to the
hecklist items of the STROBE statement seemed necessary for vet-
rinary medicine, and if so, to suggest appropriate modiﬁcations;
) attending a consensus meeting in Mississauga, Canada; and c)
elf-funding their travel to that meeting. If an initial invitation was
eclined, an alternative individual with similar expertise and from
he same geographic region was contacted using the same email
nvitation.
The steering committee also contacted the authors of the orig-
nal STROBE statement papers to inform them of our interest in
odifying the STROBE statement and to solicit support for, and
articipation in, the initiative.
.4. Identiﬁcation of speciﬁc issues
Using the approach described previously (Moher et al., 2010),
 survey was sent to the invitees soliciting input on each checklist
tem in the STROBE statement to improve relevance to observa-
ional studies related to animal health, production, welfare, and
ood safety. The intent of this survey was to guide discussion at the
onsensus meeting; thus, human ethics approval was not required.
he survey was sent by email as a spreadsheet attachment to the
nvitees, as well as to individuals who were invited, but were unable
o attend the meeting and had indicated that they still wished to
rovide input by completing the survey. The survey included the
2 items of the STROBE statement and asked the respondents to
ndicate if each item should be modiﬁed (yes/no), and if yes, to
escribe the modiﬁcations that the respondent felt would be appro-
riate. At the end of each section (Abstract, Introduction, Methods,
esults, Discussion, and Conclusion), space was provided for the
espondents to propose additional items of relevance for reportingry Medicine 134 (2016) 188–196
on studies related to animal health, production, welfare, or food
safety.
After the surveys were returned, the responses for each checklist
item were anonymously compiled.
2.5. The consensus meeting
A 2 1/2-day consensus meeting was held on May  11–13, 2014
in Mississauga, Ontario, Canada with a total of 17 participants from
Australia, Canada, Denmark, the United Kingdom, and the United
States of America, as well as two  assistants for logistical support and
documentation. Prior to the meeting, participants were provided
with an electronic copy of the STROBE statement (von Elm et al.,
2007) and its elaboration document (Vandenbroucke et al., 2007),
as well as the results of the survey. At the meeting, participants
were provided with the same materials in printed form.
The meeting began with an evening session consisting of intro-
ductions, an overview presentation on reporting guidelines in
general and their relevance to veterinary medicine, and a discus-
sion of the format for the meeting, the scope of the initiative, and
the expectations of the participants in the guideline-development
process. This included a discussion and vote on the approach that
would be used to reach consensus. To facilitate conﬁdential voting
and recording of the voting results throughout the meeting, elec-
tronic remote voting devices were used. Three voting criteria were
discussed as indicators of consensus: unanimous agreement among
the 17 experts minus 2 (88%), minus 3 (82%), or minus 5 (70%). The
participants agreed that a unanimous vote minus three persons
would be required for consensus. In same instances, experts would
leave the room for brief periods. In this case, at least 16 experts had
to participate in each vote, with unanimous vote minus three still
deﬁning consensus.
At the start of the ﬁrst full day of discussion, two of the authors
(Myriam Cevallos and Matthias Egger) of the STROBE statement
papers attended by teleconference. They provided an overview of
the process for developing the STROBE statement, common uses
and misuses, and a discussion of STROBE statement extensions.
For the remainder of the meeting, the following approach was
used for the STROBE statement checklist items 1 through 22. Ini-
tially, the moderator described the item, the key elements of that
item as presented in the STROBE elaboration document, and the
suggestions from the pre-meeting survey for modifying that item.
The discussion sessions were moderated alternately by one of two
members of the steering committee (JMS and AMOC). The moder-
ator facilitated a group discussion of the key elements, including
a discussion as to whether the proposed modiﬁcations should
result in modiﬁcation of the wording of the STROBE item. Follow-
ing the discussion, participants (including both moderators) voted
to accept or reject the modiﬁcations to the wording of the state-
ment item. If there were no modiﬁcations proposed, the vote was
to accept the item as originally written. If an item received sufﬁ-
cient votes to indicate consensus, it was  accepted. If the item did
not receive a consensus vote, it was  tabled for further discussion at
the end of the meeting. After the completion of voting on each item,
a discussion of the key elements that should be considered within
the elaboration document occurred. Participants were also asked to
provide written suggestions for discussion points to include in the
elaboration document. Two non-voting assistants served as record
keepers to record the results of the voting, take notes of the discus-
sion, and collect additional written suggestions on each item from
the participants.2.6. Preparation of reporting guidelines
After the meeting, the steering committee compiled a draft
report of the meeting that included the proposed modiﬁcations to
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he STROBE statement, a summary of the suggestions for the elabo-
ation document, and a request for feedback from the participants.
he steering committee collated the comments and suggested
evisions, and developed the modiﬁed STROBE statement for obser-
ational studies in veterinary medicine related to animal health,
roduction, welfare, or food safety outcomes. A draft of the STROBE-
et statement was previewed by graduate students (see details
n the Results section). A draft of the elaboration document was
hen prepared by the steering committee and circulated among the
articipants for input.
. Results
In total, 23 experts were invited to participate in the consensus
eeting and 14 accepted, though one invitee was  subsequently
nable to attend. The nine individuals who declined had other
ommitments, including teaching obligations during the time of
he consensus meeting. All four of the steering committee mem-
ers attended for a total of 17 participants. The methodological
xpertise of the participants included epidemiology, statistics,
ystematic review and meta-analysis, and risk assessment, with
ontent expertise in food safety, health, production, and welfare
n food-producing, companion/recreation animals (e.g., dogs, cats,
nd horses), aquaculture, and wildlife. The group was comprised
f seven individuals working in Canada, ﬁve from the United
tates, four from Europe, and one from Australia. There were 13
cademicians, three emeritus academicians, and one government
mployee. Members of the STROBE group were consulted through-
ut the process, and two members (Myriam Cevallos and Matthias
gger) participated in the ﬁrst morning of the consensus meeting.
Nineteen pre-meeting surveys were completed by 12 of the 13
nvitees, all four steering committee members, and three additional
ndividuals who were invited to the consensus meeting, but were
nable to attend. The individual who accepted the invitation but
as subsequently unable to attend the meeting did not complete
he pre-meeting survey.
The participants agreed that the scope would include obser-
ational studies using samples/information of animal origin with
utcomes related to animal health, production, welfare, or food
afety. This wording was  meant to encompass a broad range of vet-
rinary research involving animals (including animal populations
uch as herds, farms, or ﬂocks), products of animal origin (such as
eat or milk), or samples from animals (such as blood or feces).
tudies involving human health outcomes related to animal expo-
ure were considered outside the scope of this initiative. For these
tudies, the original STROBE statement would be the appropriate
uideline to use.
The participants agreed that the scope would include both
bservational studies of hypotheses (hypothesis-driven or hypoth-
sis generating) and population-based descriptive studies, such as
hose estimating the frequency and distribution of disease. At least
n the pre-harvest food safety literature, it is common for disease
requency estimates to be a key component of observational studies
Sargeant et al., 2011).
The majority of items (whether modiﬁed or not) received a con-
ensus vote the ﬁrst time that a vote was undertaken. Consensus
as not achieved on the ﬁrst vote for 2 items: item 4 and item 9.
or item 4, the discussion revolved around whether the “key ele-
ents” of study designs should be explicitly included in the item
tself. For item 9, the discussion pertained to whether euthanasia
epresented a distinct source of bias (see further discussion, below).To meet the needs for a STROBE statement for observational
tudies in veterinary research, the consensus was that the fol-
owing 16 items on the STROBE checklist needed modiﬁcation to
ake them more appropriate for veterinary medicine: 1 (title andry Medicine 134 (2016) 188–196 191
abstract), 3 (objectives), 5 (setting), 6 (participants), 7 (variables), 8
(data sources/measurement), 9 (bias), 10 (study size), 12 (statisti-
cal methods), 13 (participants), 14 (descriptive data), 15 (outcome
data), 16 (main results), 17 (other analyses), 19 (limitations), and
22 (funding) (Table 1). The participants identiﬁed the modiﬁcation
of these items as essential to the STROBE-Vet statement checklist,
rather than solely having these issues discussed in the elaboration
document.
Some of the modiﬁcations proposed to the STROBE statement
were minor wording changes intended to provide more details for
the veterinary community. For example, item 1b (abstract) was
modiﬁed to include what the participants identiﬁed as key com-
ponents of an “informative and balanced summary” (the wording
used in the original STROBE statement).
Other modiﬁcations were more substantial. For instance,
throughout the STROBE statement, reference is made to three
common observational study designs (cohort, case-control, and
cross-sectional), with the wording of some reporting recommen-
dations different for the three designs. However, in veterinary
medicine, many observational studies do not adhere strictly to
one of these three classical designs, and large population cohort
studies are rare. Therefore, the STROBE-Vet statement does not
make reference to the three common observational study designs,
but rather focuses on reporting the key features related to the
observational research. This modiﬁcation impacted items 1a, 6,
12, 14, and 15 (Table 1). An example of an addition is item 7
(variables), which now calls for the speciﬁcation of the putative
causal structure (with a causal diagram being highly encouraged)
for all hypothesis-driven studies. Another example is item 8 (data
sources), which now calls for information on questionnaire devel-
opment (if relevant). Also, throughout the STROBE statement the
word “participant” is used. In veterinary medicine, there gen-
erally are two components to the concept of “participant:” the
owner/manager of the animals included in the study population
and the animals themselves. Rather than modifying the wording for
participant throughout the checklist, a footnote was added to note
this point and to recommend that relevant information concerning
both types of “participants” should be reported.
An issue that had relevance to several of the items was  that of
non-independence of observations (items 3, 5, 6, 7, 10, 12a, 13a,
13b, 13c, 14a, 14b, and 15). It is common in veterinary medicine,
particularly in livestock and shelter medicine (where companion
animals are kenneled), for animals to be housed or managed in
groups. Individuals within groups will tend to be more similar
to each other with respect to outcome status compared to indi-
viduals in other groups, i.e. non-independence of observational
units. It is necessary to account for any non-independence of the
observational units in the design, sampling strategy, and statis-
tical analysis to avoid violating the assumption of independence
underlying many statistical procedures. The non-independence
of observational units may  be hierarchical; for instance, animals
within pens, pens within barns, barns within same-owner facil-
ities. However, this is not always the case. For example, some
organizational structures may  not be purely hierarchical (e.g.,
cross-classiﬁed data structures) and non-independence can also
result from repeated samples taken over time from the same ani-
mal  or facility (Dohoo et al., 2009). To be consistent with the
REFLECT statement (O’Connor et al., 2010; Sargeant et al., 2010)
www.reﬂect-statement.org, “organizational structure” was used
rather than “hierarchy” throughout the STROBE-Vet statement. In
addition to modifying the wording of relevant checklist items, the
elaboration document includes discussion of this issue.The ﬁnal item in the STROBE checklist pertains to funding
sources. The STROBE-Vet statement substantially expands this
item to encompass the broader concept of “transparency.” Using
numbered sub-items, the transparency item addresses sources of
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Table 1
Modiﬁcations to the original STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) statement checklist for the STROBE-Vet statement.
Item STROBE recommendation STROBE-Vet recommendation
TITLE and ABSTRACT 1 (a) Indicate the study’s design with a
commonly used term in the title or the
abstract
(a) Indicate that the study was  an observational study and, if applicable, use a common study design termc
(b) Provide in the abstract an
informative and balanced summary of
what was  done and what was found
(b) Indicate why the study was conducted, the design, the results, the limitations, and the relevance of the ﬁndings
INTRODUCTION
Background/Rationale 2 Explain the scientiﬁc background and
rationale for the investigation being
reported
Explain the scientiﬁc background and rationale for the investigation being reported
Objectives 3 State speciﬁc objectives, including any
prespeciﬁed hypotheses
(a) State speciﬁc objectives, including any primary or secondary prespeciﬁed hypotheses or their absence
(b) Ensure that the level of organizationa is clear for each objective and hypothesis
METHODS
Study design 4 Present key elements of study design
early in the paper
Present key elements of study design early in the paper
Setting 5 Describe the setting, locations, and
relevant dates, including periods of
recruitment, exposure, follow-up, and
data collection
(a) Describe the setting, locations, and relevant dates, including periods of recruitment, exposure, follow-up, and data
collection
(b)  If applicable, include information at each level of organization
Participantsb 6 (a) Cohort study—Give the eligibility
criteria, and the sources and methods
of selection of participants. Describe
methods of follow-up
Case-control study—Give the eligibility
criteria, and the sources and methods
of case ascertainment and control
selection. Give the rationale for the
choice of cases and controls
Cross-sectional study—Give the
eligibility criteria, and the sources and
methods of selection of participants
(a) Describe the eligibility criteria for the owners/managers and for the animals, at each relevant level of organization
(b) Cohort study—For matched studies,
give matching criteria and number of
exposed and unexposed
Case-control study—For matched
studies, give matching criteria and the
number of controls per case
(b) Describe the sources and methods of selection for the owners/managers and for the animals, at each relevant level
of organization
(c) Describe the method of follow-up
(d) For matched studies, describe matching criteria and the number of matched individuals per subject
(e.g., number of controls per case)
Variables 7 Clearly deﬁne all outcomes, exposures,
predictors, potential confounders, and
effect modiﬁers. Give diagnostic
criteria, if applicable
(a) Clearly deﬁne all outcomes, exposures, predictors, potential confounders, and effect modiﬁers. If applicable, give
diagnostic criteria
(b) Describe the level of organization at which each variable was measured
(c) For hypothesis-driven studies, the putative causal-structure among variables should be described
(a diagram is strongly encouraged)
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Data sources/measurement 8d For each variable of interest, give
sources of data and details of methods
of assessment (measurement).
Describe comparability of assessment
methods if there is more than one
group
(a) For each variable of interest, give sources of data and details of methods of assessment (measurement). If
applicable, describe comparability of assessment methods among groups and over time
(b) If a questionnaire was used to collect data, describe its development, validation, and administration
(c) Describe whether or not individuals involved in data collection were blinded, when applicable
(d) Describe any efforts to assess the accuracy of the data (including methods used for “data cleaning”
in primary research, or methods used for validating secondary data)
Bias 9 Describe any efforts to address
potential sources of bias
Describe any efforts to address potential sources of bias due to confounding, selection, or information bias
Study size 10 Describe how the study size was
arrived at
(a) Describe how the study size was arrived at for each relevant level of organization
(b) Describe how non-independence of measurements was incorporated into sample-size considerations,
if applicable
(c) If a formal sample-size calculation was used, describe the parameters, assumptions, and methods that were used,
including a justiﬁcation for the effect size selected
Quantitative variables 11 Explain how quantitative variables
were handled in the analyses. If
applicable, describe which groupings
were chosen, and why
Explain how quantitative variables were handled in the analyses. If applicable, describe which groupings were chosen,
and  why
Statistical methods 12 (a) Describe all statistical methods,
including those used to control for
confounding
(a) Describe all statistical methods
for each objective, at a level of detail sufﬁcient for a knowledgeable reader to replicate the methods. Include a description
of the approaches to variable selection, control of confounding, and methods used to control for non-independence
of observations
(b) Describe any methods used to
examine subgroups and interactions
(b) Describe the rationale for examining subgroups and interactions and the methods used
(c) Explain how missing data were
addressed
(c) Explain how missing data were addressed
(d)  Cohort study—If applicable, explain
how loss to follow-up was addressed
Case-control study—If applicable,
explain how matching of cases and
controls was  addressed
Cross-sectional study—If applicable,
describe analytical methods taking
account of sampling strategy
(d) If applicable,
describe the analytical approach to loss to follow-up, matching, complex sampling, and multiplicity of analyses
(e) Describe any sensitivity analyses (e) Describe any methods used to assess the robustness of the analyses (e.g., sensitivity analyses or quantitative
bias assessment)
RESULTS
Participants 13d (a) Report the numbers of individuals
at each stage of study—e.g., numbers
potentially eligible, examined for
eligibility, conﬁrmed eligible, included
in the study, completing follow-up,
and analyzed
(a) Report the numbers of owners/managers and animals at each stage of study
and at each relevant level of organization − e.g., numbers eligible, included in the study, completing follow-up, and
analyzed
(b)  Give reasons for non-participation
at each stage
(b) Give reasons for non-participation at each stage and at each relevant level of organization
(c) Consider use of a ﬂow diagram (c) Consider use of a ﬂow diagram and/or a diagram of the organizational structure
Descriptive data on
exposures and potential
confounders
14d (a) Give characteristics of study
participants (e.g., demographic,
clinical, social) and information on
exposures and potential confounders
(a) Give characteristics of study participants (e.g., demographic, clinical, social) and information on exposures and
potential confounders by group and level of organization, if applicable
(b) Indicate number of participants
with missing data for each variable of
interest
(b) Indicate number of participants with missing data for each variable of interest
and at all relevant levels of organization
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Table 1 (Continued)
Item STROBE recommendation STROBE-Vet recommendation
(c) Cohort study—Summarize follow-up
time (e.g., average and total amount)
(c) Summarize follow-up time (e.g., average and total amount), if appropriate to the study design
Outcome data 15d Cohort study—Report numbers of
outcome events or summary measures
over time
(a) Report outcomes as appropriate for the study design and summarize at all relevant levels of organization
Case-control study—Report numbers in
each exposure category, or summary
measures of exposure
(b) For proportions and rates, report the numerator and denominator
Cross-sectional study—Report numbers
of outcome events or summary
measures
(c) For continuous outcomes, report the number of observations and a measure of variability
Main results 16 (a) Give unadjusted estimates and, if
applicable, confounder-adjusted
estimates and their precision (e.g., 95%
conﬁdence interval). Make clear which
confounders were adjusted for and
why they were included
(a) Give unadjusted estimates and, if applicable, adjusted estimates and their precision (e.g., 95% conﬁdence interval).
Make clear which confounders and interactions were adjusted.
Report all relevant parameters that were part of the model
(b) Report category boundaries when
continuous variables were categorized
(b) Report category boundaries when continuous variables were categorized
(c)  If relevant, consider translating
estimates of relative risk into absolute
risk for a meaningful time period
(c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time period
Other  analyses 17 Report other analyses done—e.g.,
analyses of subgroups and interactions,
and sensitivity analyses
Report other analyses done,such as sensitivity/robustness analysis and analysis of subgroups
DISCUSSION
Key results 18 Summarize key results with reference
to study objectives
Summarize key results with reference to study objectives
Strengths and Limitations 19 Discuss limitations of the study, taking
into account sources of potential bias
or imprecision. Discuss both direction
and magnitude of any potential bias
Discuss strengths and limitations of the study, taking into account sources of potential bias or imprecision. Discuss
both  direction and magnitude of any potential bias
Interpretation 20 Give a cautious overall interpretation
of  results considering objectives,
limitations, multiplicity of analyses,
results from similar studies, and other
relevant evidence
Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of analyses, results
from  similar studies, and other relevant evidence
Generalizability 21 Discuss the generalizability (external
validity) of the study results
Discuss the generalizability (external validity) of the study results
OTHER  INFORMATION
Funding Transparency 22 Give the source of funding and the role
of the funders for the present study
and, if applicable, for the original study
on which the present article is based
(a) Funding- Give the source of funding and the role of the funders for the present study and, if applicable, for the
original study on which the present article is based
(b) Conﬂicts of interest-Describe any conﬂicts of interest, or lack thereof, for each author
(c) Describe the authors’ roles- Provision of an authors’ declaration of transparency is recommended
(d) Ethical approval- Include information on ethical approval for use of animal and human subjects
(e) Quality standards-Describe any quality standards used in the conduct of the research
a Level of organization recognizes that observational studies in veterinary research often deal with repeated measures (within an animal or herd) or animals that are maintained in groups (such as pens and herds); thus, the
observations are not statistically independent. This non-independence has profound implications for the design, analysis, and results of these studies.
b The word “participant” is used in the STROBE statement. However, for the veterinary version, it is understood that “participant” should be addressed for both the animal owner/manager and for the animals themselves.
c Underlined text represents modiﬁcations or additions to the original STROBE wording.
d Give such information separately for cases and controls in case-control studies and, if applicable, for exposed and unexposed groups in cohort and cross-sectional studies.
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unding, conﬂicts of interest, authors’ roles, ethical approval (ani-
al, human, or data use, as applicable), and the use of any quality
tandards.
There was considerable discussion during the meeting on the
igniﬁcance of euthanasia in veterinary medicine. It is possible, and
ommon under some disease or production circumstances, for ani-
als to be euthanized or electively culled during studies. There is no
quivalent to this in human medicine; therefore, much discussion
as devoted to this topic. Although the participants agreed that
he occurrence and frequency of euthanasia or culling should be
eported in studies where it occurred, there were differing opinions
s to whether euthanasia is a distinct issue related to the potential
or information or selection bias, or whether it is just a component
f a death/survival outcome that needs to be reported. At the end
f the meeting, a vote was held and the consensus was  to include
 discussion of euthanasia in the elaboration document, but not to
odify the wording within the STROBE-Vet expansion.
The draft statement was previewed by 17 graduate students
rom two graduate student journal clubs (Epidemiology Journal
lub and Ruminant Group Journal Club) in the Department of Popu-
ation Medicine at the University of Guelph. The students identiﬁed
hrases for which they would like clariﬁcation or further expla-
ation. Their comments were incorporated into the elaboration
ocument.
. Discussion
Here, the development of an extension to the STROBE state-
ent for reporting observational studies in veterinary research is
escribed. The intention of these guidelines, in concordance with
he STROBE statement, is to provide guidance for authors when
escribing the design and results of observational studies. The
uidelines are also useful for editors, peer-reviewers, and readers of
bservational study reports. It is intended that these guidelines will
e applicable to the broad range of research questions addressed in
eterinary medicine using observational studies, including stud-
es in which the objective was to describe disease occurrence,
xploratory studies used to generate hypotheses, and hypothesis-
riven studies. The guidelines are applicable to research conducted
n both developed and developing nations. It is not the inten-
ion for these guidelines to be prescriptive regarding format or
rder of reporting based on the item numbering. The items in the
TROBE-Vet expansion were ordered to correspond to the items
n the STROBE statement, which follows the typical order of sec-
ions within a scientiﬁc manuscript. It is important that all of the
elevant checklist items are addressed in sufﬁcient detail within a
anuscript.
The STROBE-Vet guidelines are also not intended to be prescrip-
ive about the conduct of observational studies, but rather they
ocus on the clarity of reporting similar to that of the STROBE state-
ent (Vandenbroucke, 2007). Likewise, the STROBE-Vet statement
s also not intended to be used as a tool to assess the quality of the
esearch design or execution (von Elm et al., 2007). Both the issue
f prescriptive design and use for quality assessment have been
dentiﬁed in the literature as misuses of the STROBE statement (da
osta et al., 2011). There are several systematic reviews published
n quality assessment tools for observational research (Sanderson
t al., 2007; Shamliyan et al., 2010; Jarde et al., 2012).
The guidelines presented herein represent the consensus of a
roup of individuals deemed to be experts in observational stud-
es in veterinary research, and thus the results represent expert
pinion. A systematic review of published literature was not con-
ucted for any of the items and published evidence was not always
vailable to support modiﬁcation to or inclusion of an item. The
teering committee attempted to balance content expertise and,ry Medicine 134 (2016) 188–196 195
to some extent, geographical location of the selected participants.
However, the existing networks of the steering committee mem-
bers inﬂuenced participant selection, the necessity for the experts
to self-fund their travel resulted in a predominance of North Ameri-
can experts, and the steering committee members knew each other
professionally prior to this initiative. Therefore, there is the poten-
tial for selection bias to have impacted our results. We  expect that
these guidelines will evolve over time and we welcome comments
or suggestions. When used in conjunction with the Explanation
and Elaboration document, we  expect that these guidelines will
lead to improved reporting of observational research in veterinary
medicine.
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